All Stories

  1. Evasion of MAIT cell recognition by the African Salmonella Typhimurium ST313 pathovar that causes invasive disease
  2. Cross‐reactivity of hepatitis C virus specific vaccine‐induced T cells at immunodominant epitopes
  3. Biology of CD1- and MR1-Restricted T Cells
  4. Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation
  5. Harnessing CD1d‐restricted iNKT cells to design novel vaccination strategies
  6. Globosides but Not Isoglobosides Can Impact the Development of Invariant NKT Cells and Their Interaction with Dendritic Cells
  7. Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann‐Pick disease type C
  8. Faculty Opinions recommendation of Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells.
  9. Reply to "Failure to detect production of IL-10 by activated human neutrophils"
  10. Invariant NKT Cell-Based Vaccine Strategies
  11. Centriole polarisation to the immunological synapse directs secretion from cytolytic cells of both the innate and adaptive immune systems
  12. Binding Strength and Dynamics of Invariant Natural Killer Cell T Cell Receptor/CD1d-Glycosphingolipid Interaction on Living Cells by Single Molecule Force Spectroscopy
  13. Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
  14. Faculty Opinions recommendation of Invariant NKT cells limit activation of autoreactive CD1d-positive B cells.
  15. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A
  16. Characterization of human DNGR-1 + BDCA3 + leukocytes as putative equivalents of mouse CD8α + dendritic cells
  17. Improved localization of cellular membrane receptors using combined fluorescence microscopy and simultaneous topography and recognition imaging
  18. Recent advances in processing and presentation of CD1 bound lipid antigens
  19. Linking Inflammation to Natural Killer T Cell Activation
  20. Nonglycosidic Agonists of Invariant NKT Cells for Use as Vaccine Adjuvants
  21. Harnessing invariant NKT cells in vaccination strategies
  22. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
  23. Structural and Functional Aspects of Lipid Binding by CD1 Molecules
  24. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell helpin vivo
  25. Cutting Edge: Nonglycosidic CD1d Lipid Ligands Activate Human and Murine Invariant NKT Cells
  26. Phage display‐derived recombinant antibodies with TCR‐like specificity against α‐galactosylceramide and its analogues in complex with human CD1d molecules
  27. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity
  28. Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus
  29. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation
  30. T cell receptors get back to basics
  31. A closer look at CD1d molecules: new horizons in studying NKT cells
  32. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals
  33. Dendritic Cell Function Can Be Modulated through Cooperative Actions of TLR Ligands and Invariant NKT Cells
  34. Modulation of CD103 Expression on Human Colon Carcinoma-Specific CTL
  35. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
  36. Role of Immunoproteasomes in Cross-Presentation
  37. Expression of MHC Class I–Related Chain B (MICB) Molecules on Renal Transplant Biopsies
  38. Viral Immunity: Cross-Priming with the Help of TLR3
  39. Mature dendritic cells differentiated in the presence of interferon-b and interleukin-3 prime functional antigen-specific CD8+ T cells
  40. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
  41. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
  42. Impact of Alpha Interferon and Ribavirin on the Function of Maturing Dendritic Cells
  43. Lack of dendritic cell maturation by the plant toxin ricin
  44. Biological function of the soluble CEACAM1 protein and implications in TAP2‐deficient patients
  45. Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection
  46. CpG-matured Murine Plasmacytoid Dendritic Cells Are Capable of In Vivo Priming of Functional CD8 T Cell Responses to Endogenous but Not Exogenous Antigens
  47. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo
  48. Intravenous Injection of a Lentiviral Vector Encoding NY-ESO-1 Induces an Effective CTL Response
  49. Dendritic cells: a journey from laboratory to clinic
  50. Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: Manifestation of a dual activation threshold
  51. High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining
  52. NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells
  53. Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells
  54. Generation of CD1 tetramers as a tool to monitor glycolipid-specific T cells
  55. Plasmacytoid dendritic cells prime IFN‐γ‐secreting melanoma‐specific CD8 lymphocytes and are found in primary melanoma lesions
  56. The use of HLA class I tetramers to design a vaccination strategy for melanoma patients
  57. V 24-J Q-Independent, CD1d-Restricted Recognition of  -Galactosylceramide by Human CD4+ and CD8  + T Lymphocytes
  58. Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols
  59. Mature Dendritic Cells Prime Functionally Superior Melan-A-Specific CD8+ Lymphocytes as Compared with Nonprofessional APC
  60. A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response
  61. Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells
  62. Inhibition of dendritic cell maturation by herpes simplex virus
  63. Inhibition of dendritic cell maturation by herpes simplex virus
  64. Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA
  65. Expression of a CD3 epsilon transgene in CD3 epsilon(null) mice does not restore CD3 gamma and delta expression but efficiently rescues T cell development from a subpopulation of prothymocytes.
  66. Essential and Partially Overlapping Role of CD3γ and CD3δ for Development of αβ and γδ T Lymphocytes
  67. Selective Inhibition of Ii-dependent Antigen Presentation byHelicobacter pyloriToxin VacA
  68. Quantitative Contribution of CD4 and CD8 to T Cell Antigen Receptor Serial Triggering
  69. Agonist‐induced T cell receptor down‐regulation: molecular requirements and dissociation from T cell activation
  70. Mechanisms of antigen-induced TCR downregulation
  71. Mechanisms of antigen-induced TCR downregulation
  72. CD4 and CD8 can be recruited to triggered T cell receptors in the absence of interaction with the cognate MHC molecules
  73. The angiogenesis induced by HIV–1 Tat protein is mediated by the Flk–1/KDR receptor on vascular endothelial cells
  74. Over-expression of CD3ε transgenes blocks T lymphocyte development
  75. Harnessing NKT Cells for Therapeutic Applications